4.4 Article

Mapping ligand-receptor interfaces: Approaching the resolution limit of benzophenone-based photoaffinity scanning

Journal

CHEMICAL BIOLOGY & DRUG DESIGN
Volume 71, Issue 4, Pages 380-383

Publisher

WILEY
DOI: 10.1111/j.1747-0285.2008.00646.x

Keywords

molecular modeling; parathyroid hormone receptor; rho-benzoylphenylalanine; photoaffinity crosslinking; resolution limit

Funding

  1. NIDDK NIH HHS [R01 DK047940, R01 DK047940-11, R01 DK047940-13, R01 DK047940-12, DK-47940] Funding Source: Medline
  2. NIGMS NIH HHS [R29 GM054082, GM-54082, R01 GM054082] Funding Source: Medline

Ask authors/readers for more resources

Photoaffinity crosslinking has yielded important insights in the study of G protein-coupled receptors and the mode of ligand binding. The most widely used photolabile moiety is p-benzoylphenylalanine largely because of its reportedly high site specificity, reduced reactivity to water and light, photokinetics, and ease of incorporation into peptide ligands during synthesis. However, in the course of our studies directed at characterizing the binding of parathyroid hormone to its cognate G protein-coupled receptor, we find that inherent properties of p-benzoylphenylalanine, such as its size and conformational flexibility, limit the resulting resolution of the ligand-receptor structure. Here, we examine and define these limits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
Article Biochemistry & Molecular Biology

Dihydropyrimidine derivatives as MDM2 inhibitors

Ali Mehri, Karim Mahnam, Hajar Sirous, Mahmoud Aghaei, Leila Rafiei, Mahboubeh Rostami

Summary: One potential approach for tumor therapy is inhibiting the binding between MDM2 and p53 to reactivate p53 in tumor cells. In this study, Monastrol derivatives were designed as MDM2 inhibitors and evaluated for their cytotoxicity on cancer cells. Compound 5d showed the best inhibitory results in silico and in vitro experiments. These findings suggest that Monastrol derivatives have the potential to be candidates for MDM2 inhibition.

CHEMICAL BIOLOGY & DRUG DESIGN (2024)